PHIL Inter Pharma

CDMO

Vietnam

https://philipharma.com/

Is this your company? Claim this profile

Drug Product

Company Overview

About

PHIL Inter Pharma is a pharmaceutical CDMO offering comprehensive services.

Key Expertise

Specialized in Gene Therapy, Cell Therapy, mRNA

Therapeutic Areas

Respiratory

Allergy

Quick Facts

HQ:Vietnam

Founded:2009

Employees:1,177

Capabilities & Services

Core Capabilities

Biologics Drug Substance
Biologics Manufacturing
Formulation Development

Types of Organization

GMP Manufacturing

Quality Systems

Regulatory Support

Dosage Forms

Sterile Injectable

Production Scales

Commercial Scale

Large Scale (Metric Ton+)

Markets Served

North America

Europe

International Regulatory

EU GMP Certificates

Regulatory Bodies

EMA/EudraGMDP

Regulatory Approvals

Drug Approval 28OC17

Health Canada · #APR-8YPGVB1U · 2022-09-01

Drug Approval OT70WQ

Health Canada · #APR-4WDC3MIC · 2018-07-01

Case Studies

0 published case studies showcasing past projects, challenges and outcomes.

Certifications

FDA Registration

U.S. Food and Drug Administration

Cert #: CERT-HOVJIV7O

Issued: 2020-09-28

Expires: 2025-09-14

ISO 13485:2016

International Organization for Standardization

Cert #: CERT-S0DHXRCJ

Issued: 2020-05-10

Expires: 2025-12-18

MHRA GMP

UK Medicines and Healthcare products Regulatory Agency

Cert #: CERT-JCKFZRSJ

Issued: 2020-08-04

Expires: 2025-12-01

Health Canada GMP

Health Canada

Cert #: CERT-N6W89VQB

Issued: 2020-09-17

Expires: 2025-04-28

Loading CDMO intelligence...

Request an Introduction

Please log in to contact this provider.

Key facts about PHIL Inter Pharma

PHIL Inter Pharma is headquartered in Vietnam.
PHIL Inter Pharma was founded in 2009.
PHIL Inter Pharma has 1,177 employees.
PHIL Inter Pharma's capabilities include Biologics Drug Substance, Biologics Manufacturing and Formulation Development.

Find CDMOs like PHIL Inter Pharma

Directory pages this company appears in, each with the full list of matching manufacturers.

Biologics Drug Substance CDMOs Formulation Development CDMOs Sterile Injectable CDMOs